Suppr超能文献

综述:幽门螺杆菌对阿尔茨海默病的影响:目前我们了解多少?

Review: Impact of Helicobacter pylori on Alzheimer's disease: What do we know so far?

机构信息

Department of Internal Medicine, Bürgerspital Hospital, Solothurn, Switzerland.

Department of Internal Medicine, Agios Pavlos General Hospital, Thessaloniki, Macedonia, Greece.

出版信息

Helicobacter. 2018 Feb;23(1). doi: 10.1111/hel.12454. Epub 2017 Nov 27.

Abstract

BACKGROUND

Helicobacter pylori has changed radically gastroenterologic world, offering a new concept in patients' management. Over time, more medical data gave rise to diverse distant, extragastric manifestations and interactions of the "new" discovered bacterium. Special interest appeared within the field of neurodegenerative diseases and particularly Alzheimer's disease, as the latter and Helicobacter pylori infection are associated with a large public health burden and Alzheimer's disease ranks as the leading cause of disability. However, the relationship between Helicobacter pylori infection and Alzheimer's disease remains uncertain.

METHODS

We performed a narrative review regarding a possible connection between Helicobacter pylori and Alzheimer's disease. All accessible relevant (pre)clinical studies written in English were included. Both affected pathologies were briefly analyzed, and relevant studies are discussed, trying to focus on the possible pathogenetic role of this bacterium in Alzheimer's disease.

RESULTS

Data stemming from both epidemiologic studies and animal experiments seem to be rather encouraging, tending to confirm the hypothesis that Helicobacter pylori infection might influence the course of Alzheimer's disease pleiotropically. Possible main mechanisms may include the bacterium's access to the brain via the oral-nasal-olfactory pathway or by circulating monocytes (infected with Helicobacter pylori due to defective autophagy) through disrupted blood-brain barrier, thereby possibly triggering neurodegeneration.

CONCLUSIONS

Current data suggest that Helicobacter pylori infection might influence the pathophysiology of Alzheimer's disease. However, further large-scale randomized controlled trials are mandatory to clarify a possible favorable effect of Helicobacter pylori eradication on Alzheimer's disease pathophysiology, before the recommendation of short-term and cost-effective therapeutic regimens against Helicobacter pylori-related Alzheimer's disease.

摘要

背景

幽门螺杆菌彻底改变了胃肠病学领域,为患者的治疗提供了新的概念。随着时间的推移,更多的医学数据引发了各种不同的、胃外的表现和这种“新”发现的细菌的相互作用。在神经退行性疾病领域,特别是阿尔茨海默病领域,人们产生了特殊的兴趣,因为后者和幽门螺杆菌感染与巨大的公共卫生负担有关,而阿尔茨海默病是导致残疾的主要原因。然而,幽门螺杆菌感染与阿尔茨海默病之间的关系仍不确定。

方法

我们对幽门螺杆菌和阿尔茨海默病之间可能存在的联系进行了叙述性综述。纳入了所有可获得的、以英语撰写的相关(临床前)研究。简要分析了两种受影响的病理,并讨论了相关的研究,试图重点关注这种细菌在阿尔茨海默病中的可能致病作用。

结果

来自流行病学研究和动物实验的数据似乎相当令人鼓舞,倾向于证实幽门螺杆菌感染可能通过多种途径影响阿尔茨海默病的病程这一假说。可能的主要机制包括细菌通过口腔-鼻腔-嗅觉途径或通过循环单核细胞(由于自噬缺陷而感染幽门螺杆菌)进入大脑,从而通过破坏血脑屏障引发神经退行性变。

结论

目前的数据表明,幽门螺杆菌感染可能影响阿尔茨海默病的病理生理学。然而,在推荐针对与幽门螺杆菌相关的阿尔茨海默病的短期、成本效益好的治疗方案之前,还需要进行更大规模的随机对照试验来阐明幽门螺杆菌根除可能对阿尔茨海默病病理生理学产生有利影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验